ArticleScience advances2019

Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth.

Tsuyoshi Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.